Risk-to-benefit ratio of inhaled corticosteroids in patients with COPD

David Price* (Corresponding Author), Barbara Yawn, Guy Brusselle, Andrea Rossi

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

150 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Risk-to-benefit ratio of inhaled corticosteroids in patients with COPD'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences